药物基因 (DrugGen):一个针对特定标蛋白的新生成分子结合剂的数据库
Hao Qian1, Jingyuan Zhou1, Shikui Tu1
1Department of Computer Science and Engineering, Shanghai Jiao Tong University, No. 800 Dong Chuan Road, Shanghai 200240, China.
Database : the journal of biological databases and curation
|December 27, 2023
概括
我们使用6个人工智能 (AI) 模型创建了一个3D连体数据库,用于新的分子生成. 这种资源通过为特定的蛋白质标设计的新分子提供帮助药物发现.
科学领域:
- 计算化学是一种计算化学.
- 药物发现 药物发现
- 生物信息学是一种生物信息学.
背景情况:
- De novo分子生成通过创建针对特定蛋白质的新分子来加速药物发现.
- 人工智能 (AI) 和机器学习 (ML) 对于从头开始设计分子越来越重要.
- 现有的计算工具需要有效的数据库来探索人工智能驱动的分子设计.
研究的目的:
- 开发使用人工智能生成的3D联体的用户友好数据库.
- 为选潜在药物化合物与疾病相关的标提供资源.
- 为了使不同的人工智能模型能够进行 de novo 分子生成的比较.
主要方法:
- 编制了来自6个AI模型的3D连体数据库,用于新的分子生成.
- 数据库中包括了20个与疾病相关的目标和1767个蛋白质目标.
- 为各种目标生成多达164,107个新设计的分子.
主要成果:
- 建立了一个包括1767个蛋白质标和164,107个新设计的分子的综合数据库.
- 该数据库有助于有效选潜在的候选药物.
- 为评估和比较分子生成中的AI模型性能提供了一个平台.
结论:
- 开发的数据库为药物发现专业人员提供了有价值的,可访问的资源.
- 它支持探索人工智能驱动的de novo分子生成用于治疗开发.
- 在https://cmach.sjtu.edu.cn/drug/上公开访问,促进研究和合作.
相关概念视频
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Ligand Binding Sites
12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Protein-Drug Binding: Determination Methods
194
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
194
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Drug-Receptor Bonds
2.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.8K


